English
Insider transactions
EDGARInvivyd, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 20 transactions, 455,196 shares
- Sum of shares × price per share: 531,320.8594
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 54
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 Filed 2026-09-02 | Sheffield Ian Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 100,000 | 0 | — | 100,000 | Direct (D) | No | F1
| Open filing 0001193125-26-380337 Read from the filing’s XML Dispute this row |
| 2026-08-30 Filed 2026-09-01 | Elia Marc Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 10,700,000 | 0 | — | 10,700,000 | Direct (D) | No | F1
| Open filing 0001193125-26-378862 Read from the filing’s XML Dispute this row |
| 2026-08-18 Filed 2026-08-18 | Green Julie Officer: Chief Human Resources Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 18,425 | 0.8429 | 15,530.4325Derived: shares × price per share. Exact value 15530.4325. | 168,937 | Direct (D) | Yes | F2, F4
| Open filing 0001193125-26-355914 Read from the filing’s XML Dispute this row |
| 2026-08-18 Filed 2026-08-18 | Duke William E. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 18,425 | 0.8429 | 15,530.4325Derived: shares × price per share. Exact value 15530.4325. | 168,937 | Direct (D) | Yes | F2, F4
| Open filing 0001193125-26-355913 Read from the filing’s XML Dispute this row |
| 2026-08-18 Filed 2026-08-18 | Lee Timothy Edward Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 18,425 | 0.8429 | 15,530.4325Derived: shares × price per share. Exact value 15530.4325. | 178,937 | Direct (D) | Yes | F2, F4
| Open filing 0001193125-26-355915 Read from the filing’s XML Dispute this row |
| 2026-08-18 Filed 2026-08-18 | Andersen Jill Officer: Chief Legal Officer, Secretary | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 30,706 | 0.8429 | 25,882.0874Derived: shares × price per share. Exact value 25882.0874. | 283,774 | Direct (D) | Yes | F2, F4
| Open filing 0001193125-26-355912 Read from the filing’s XML Dispute this row |
| 2026-08-18 Filed 2026-08-18 | Allen Robert D. III Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 17,043 | 0.8429 | 14,365.5447Derived: shares × price per share. Exact value 14365.5447. | 178,765 | Direct (D) | Yes | F2, F4
| Open filing 0001193125-26-355911 Read from the filing’s XML Dispute this row |
| 2026-08-17 Filed 2026-08-18 | Green Julie Officer: Chief Human Resources Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 22,355 | 0.7220 | 16,140.31Derived: shares × price per share. Exact value 16140.3100. | 187,362 | Direct (D) | Yes | F2, F3
| Open filing 0001193125-26-355914 Read from the filing’s XML Dispute this row |
| 2026-08-17 Filed 2026-08-18 | Duke William E. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 22,355 | 0.7220 | 16,140.31Derived: shares × price per share. Exact value 16140.3100. | 187,362 | Direct (D) | Yes | F2, F3
| Open filing 0001193125-26-355913 Read from the filing’s XML Dispute this row |
| 2026-08-17 Filed 2026-08-18 | Lee Timothy Edward Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 22,355 | 0.7220 | 16,140.31Derived: shares × price per share. Exact value 16140.3100. | 197,362 | Direct (D) | Yes | F2, F3
| Open filing 0001193125-26-355915 Read from the filing’s XML Dispute this row |
| 2026-08-17 Filed 2026-08-18 | Andersen Jill Officer: Chief Legal Officer, Secretary | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 37,256 | 0.7220 | 26,898.832Derived: shares × price per share. Exact value 26898.8320. | 314,480 | Direct (D) | Yes | F2, F3
| Open filing 0001193125-26-355912 Read from the filing’s XML Dispute this row |
| 2026-08-17 Filed 2026-08-18 | Allen Robert D. III Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 20,679 | 0.7220 | 14,930.238Derived: shares × price per share. Exact value 14930.2380. | 195,808 | Direct (D) | Yes | F2, F3
| Open filing 0001193125-26-355911 Read from the filing’s XML Dispute this row |
| 2026-08-15 Filed 2026-08-18 | Green Julie Officer: Chief Human Resources Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 102,000 | — | — | 209,717 | Direct (D) | Yes | F1
| Open filing 0001193125-26-355914 Read from the filing’s XML Dispute this row |
| 2026-08-15 Filed 2026-08-18 | Green Julie Officer: Chief Human Resources Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 102,000 | 0 | — | 0 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-355914 Read from the filing’s XML Dispute this row |
| 2026-08-15 Filed 2026-08-18 | Duke William E. Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 102,000 | — | — | 209,717 | Direct (D) | Yes | F1
| Open filing 0001193125-26-355913 Read from the filing’s XML Dispute this row |
| 2026-08-15 Filed 2026-08-18 | Duke William E. Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 102,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-355913 Read from the filing’s XML Dispute this row |
| 2026-08-15 Filed 2026-08-18 | Lee Timothy Edward Officer: Chief Commercial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 102,000 | — | — | 219,717 | Direct (D) | Yes | F1
| Open filing 0001193125-26-355915 Read from the filing’s XML Dispute this row |
| 2026-08-15 Filed 2026-08-18 | Lee Timothy Edward Officer: Chief Commercial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 102,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-355915 Read from the filing’s XML Dispute this row |
| 2026-08-15 Filed 2026-08-18 | Andersen Jill Officer: Chief Legal Officer, Secretary | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 170,000 | — | — | 351,736 | Direct (D) | Yes | F1
| Open filing 0001193125-26-355912 Read from the filing’s XML Dispute this row |
| 2026-08-15 Filed 2026-08-18 | Andersen Jill Officer: Chief Legal Officer, Secretary | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 170,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-355912 Read from the filing’s XML Dispute this row |
| 2026-08-15 Filed 2026-08-18 | Allen Robert D. III Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 102,000 | — | — | 216,487 | Direct (D) | Yes | F1
| Open filing 0001193125-26-355911 Read from the filing’s XML Dispute this row |
| 2026-08-15 Filed 2026-08-18 | Allen Robert D. III Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 102,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-355911 Read from the filing’s XML Dispute this row |
| 2026-07-31 Filed 2026-08-04 | Mina Michael Officer: CMO and Chief Epidemiologist | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 1,125,000 | 0 | — | 1,125,000 | Direct (D) | No | F1
| Open filing 0001193125-26-332844 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | Elia Marc Director · Other: See RemarksM28 Capital Management LP Other: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0001193125-26-234661 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | Royan Ajay Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0001193125-26-234666 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | MCGUIRE TERRANCE Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0001193125-26-234662 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | BOLNO PAUL Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 32,876 | 0 | — | 32,876 | Direct (D) | No | F1
| Open filing 0001193125-26-234660 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | MCLAUGHLIN KEVIN F Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0001193125-26-234665 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-21 | Berry Tamsin Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0001193125-26-234656 Read from the filing’s XML Dispute this row |
| 2026-02-18 Filed 2026-02-18 | Green Julie Officer: Chief Human Resources Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 20,964 | 1.5778 | 33,076.9992Derived: shares × price per share. Exact value 33076.9992. | 107,717 | Direct (D) | Yes | F2, F4
| Open filing 0001193125-26-057822 Read from the filing’s XML Dispute this row |
| 2026-02-18 Filed 2026-02-18 | Andersen Jill Officer: Chief Legal Officer, Secretary | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 34,939 | 1.5778 | 55,126.7542Derived: shares × price per share. Exact value 55126.7542. | 181,736 | Direct (D) | Yes | F2, F4
| Open filing 0001193125-26-057814 Read from the filing’s XML Dispute this row |
| 2026-02-18 Filed 2026-02-18 | Lee Timothy Edward Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 20,964 | 1.5778 | 33,076.9992Derived: shares × price per share. Exact value 33076.9992. | 117,717 | Direct (D) | Yes | F3, F5
| Open filing 0001193125-26-057815 Read from the filing’s XML Dispute this row |
| 2026-02-18 Filed 2026-02-18 | Allen Robert D. III Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 19,392 | 1.5778 | 30,596.6976Derived: shares × price per share. Exact value 30596.6976. | 114,487 | Direct (D) | Yes | F2, F4
| Open filing 0001193125-26-057828 Read from the filing’s XML Dispute this row |
| 2026-02-18 Filed 2026-02-18 | Duke William E. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 20,964 | 1.5778 | 33,076.9992Derived: shares × price per share. Exact value 33076.9992. | 107,717 | Direct (D) | Yes | F2, F4
| Open filing 0001193125-26-057819 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-02-18 | Green Julie Officer: Chief Human Resources Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 19,663 | 1.5396 | 30,273.1548Derived: shares × price per share. Exact value 30273.1548. | 128,681 | Direct (D) | Yes | F2, F3
| Open filing 0001193125-26-057822 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-02-18 | Andersen Jill Officer: Chief Legal Officer, Secretary | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 32,771 | 1.5396 | 50,454.2316Derived: shares × price per share. Exact value 50454.2316. | 216,675 | Direct (D) | Yes | F2, F3
| Open filing 0001193125-26-057814 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-02-18 | Lee Timothy Edward Officer: Chief Commercial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 19,663 | 1.5396 | 30,273.1548Derived: shares × price per share. Exact value 30273.1548. | 138,681 | Direct (D) | Yes | F3, F4
| Open filing 0001193125-26-057815 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-02-18 | Allen Robert D. III Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 18,189 | 1.5396 | 28,003.7844Derived: shares × price per share. Exact value 28003.7844. | 133,879 | Direct (D) | Yes | F2, F3
| Open filing 0001193125-26-057828 Read from the filing’s XML Dispute this row |
| 2026-02-17 Filed 2026-02-18 | Duke William E. Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 19,663 | 1.5396 | 30,273.1548Derived: shares × price per share. Exact value 30273.1548. | 128,681 | Direct (D) | Yes | F2, F3
| Open filing 0001193125-26-057819 Read from the filing’s XML Dispute this row |
| 2026-02-15 Filed 2026-02-18 | Green Julie Officer: Chief Human Resources Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 99,000 | — | — | 148,344 | Direct (D) | Yes | F1
| Open filing 0001193125-26-057822 Read from the filing’s XML Dispute this row |
| 2026-02-15 Filed 2026-02-18 | Green Julie Officer: Chief Human Resources Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 99,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 102,000 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-057822 Read from the filing’s XML Dispute this row |
| 2026-02-15 Filed 2026-02-18 | Andersen Jill Officer: Chief Legal Officer, Secretary | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 165,000 | — | — | 249,446 | Direct (D) | Yes | F1
| Open filing 0001193125-26-057814 Read from the filing’s XML Dispute this row |
| 2026-02-15 Filed 2026-02-18 | Andersen Jill Officer: Chief Legal Officer, Secretary | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 165,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 170,000 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-057814 Read from the filing’s XML Dispute this row |
| 2026-02-15 Filed 2026-02-18 | Lee Timothy Edward Officer: Chief Commercial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 99,000 | — | — | 158,344 | Direct (D) | Yes | F1, F2
| Open filing 0001193125-26-057815 Read from the filing’s XML Dispute this row |
| 2026-02-15 Filed 2026-02-18 | Lee Timothy Edward Officer: Chief Commercial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 99,000 | 0 | — | 102,000 | Direct (D) | Yes | F1, F6
| Open filing 0001193125-26-057815 Read from the filing’s XML Dispute this row |
| 2026-02-15 Filed 2026-02-18 | Allen Robert D. III Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 99,000 | — | — | 152,068 | Direct (D) | Yes | F1
| Open filing 0001193125-26-057828 Read from the filing’s XML Dispute this row |
| 2026-02-15 Filed 2026-02-18 | Allen Robert D. III Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 99,000 | 0 | — | 102,000 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-057828 Read from the filing’s XML Dispute this row |
| 2026-02-15 Filed 2026-02-18 | Duke William E. Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 99,000 | — | — | 148,344 | Direct (D) | Yes | F1
| Open filing 0001193125-26-057819 Read from the filing’s XML Dispute this row |
| 2026-02-15 Filed 2026-02-18 | Duke William E. Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 99,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 102,000 | Direct (D) | Yes | F1, F5
| Open filing 0001193125-26-057819 Read from the filing’s XML Dispute this row |
| 2026-01-29 Filed 2026-01-30 | Lee Timothy Edward Officer: Chief Commercial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 675,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 675,000 | Direct (D) | No | F1
| Open filing 0001193125-26-031840 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Perceptive Advisors LLC Common Stock, $0.0001 par value per share | 4.7 | 13,762,637 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-463811 Dispute this row |
| Joseph Edelman Common Stock, $0.0001 par value per share | 4.7 | 13,762,637 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-463811 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.0001 par value per share | 4.7 | 13,762,637 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-463811 Dispute this row |
| Maverick Capital, Ltd. Common Stock, $0.0001 par value per share | 8.3 | 24,442,160 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001012975-26-001059 Dispute this row |
| Maverick Capital Management, LLC Common Stock, $0.0001 par value per share | 8.3 | 24,442,160 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001012975-26-001059 Dispute this row |
| Lee S. Ainslie III Common Stock, $0.0001 par value per share | 8.3 | 24,442,160 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001012975-26-001059 Dispute this row |
| Perceptive Advisors LLC Common Stock, $0.0001 par value per share | 6.3 | 18,490,636 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-352642 Dispute this row |
| Joseph Edelman Common Stock, $0.0001 par value per share | 6.3 | 18,490,636 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-352642 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.0001 par value per share | 6.3 | 18,490,636 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-352642 Dispute this row |
| BIOTECHNOLOGY VALUE FUND L P Common Stock, $0.0001 par value per share | 5.4 | 16,031,969.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-002171 Dispute this row |
| BVF I GP LLC Common Stock, $0.0001 par value per share | 5.4 | 16,031,969.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-002171 Dispute this row |
| BIOTECHNOLOGY VALUE FUND II LP Common Stock, $0.0001 par value per share | 3.8 | 11,183,991.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-002171 Dispute this row |
| BVF II GP LLC Common Stock, $0.0001 par value per share | 3.8 | 11,183,991.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-002171 Dispute this row |
| Biotechnology Value Trading Fund OS LP Common Stock, $0.0001 par value per share | 0.6 | 1,887,918.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-002171 Dispute this row |
| BVF Partners OS Ltd. Common Stock, $0.0001 par value per share | 0.6 | 1,887,918.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-002171 Dispute this row |
| BVF GP HOLDINGS LLC Common Stock, $0.0001 par value per share | 9.2 | 27,215,960.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-002171 Dispute this row |
| BVF PARTNERS L P/IL Common Stock, $0.0001 par value per share | 9.99 | 29,571,826.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-002171 Dispute this row |
| BVF INC/IL Common Stock, $0.0001 par value per share | 9.99 | 29,571,826.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-002171 Dispute this row |
| LAMPERT MARK N Common Stock, $0.0001 par value per share | 9.99 | 29,571,826.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-26-002171 Dispute this row |
| BlackRock, Inc. Common Stock | 5.5 | 16,124,696 | 06/30/2026 Filed 2026-07-28 | SCHEDULE 13G | Open filing 0002012383-26-002467 Dispute this row |
| Point72 Asset Management, L.P. Common Stock, par value $0.0001 per share | 0 | 43,931.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000919574-26-003489 Dispute this row |
| Point72 Capital Advisors, Inc. Common Stock, par value $0.0001 per share | 0 | 43,931.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000919574-26-003489 Dispute this row |
| Steven A. Cohen Common Stock, par value $0.0001 per share | 0 | 43,931.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0000919574-26-003489 Dispute this row |
| RA Capital Management, L.P. Common Stock, $0.0001 par value per share | 7.0 | 21,342,442.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001346824-26-000155 Dispute this row |
| Peter Kolchinsky Common Stock, $0.0001 par value per share | 7.0 | 21,342,442.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001346824-26-000155 Dispute this row |
| Rajeev Shah Common Stock, $0.0001 par value per share | 7.0 | 21,342,442.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001346824-26-000155 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, $0.0001 par value per share | 7.0 | 21,342,442.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001346824-26-000155 Dispute this row |
| Point72 Asset Management, L.P. Common Stock, par value $0.0001 per share | 6.0 | 16,653,036.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000902664-26-001128 Dispute this row |
| Point72 Capital Advisors, Inc. Common Stock, par value $0.0001 per share | 6.0 | 16,653,036.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000902664-26-001128 Dispute this row |
| Steven A. Cohen Common Stock, par value $0.0001 per share | 6.0 | 16,653,036.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0000902664-26-001128 Dispute this row |
| BIOTECHNOLOGY VALUE FUND L P Common Stock, $0.0001 par value per share | 4.9 | 13,619,218.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-000469 Dispute this row |
| BVF I GP LLC Common Stock, $0.0001 par value per share | 4.9 | 13,619,218.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-000469 Dispute this row |
| BIOTECHNOLOGY VALUE FUND II LP Common Stock, $0.0001 par value per share | 3.6 | 9,954,397.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-000469 Dispute this row |
| BVF II GP LLC Common Stock, $0.0001 par value per share | 3.6 | 9,954,397.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-000469 Dispute this row |
| Biotechnology Value Trading Fund OS LP Common Stock, $0.0001 par value per share | 0.6 | 1,563,852.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-000469 Dispute this row |
| BVF Partners OS Ltd. Common Stock, $0.0001 par value per share | 0.6 | 1,563,852.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-000469 Dispute this row |
| BVF GP HOLDINGS LLC Common Stock, $0.0001 par value per share | 8.3 | 23,573,615.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-000469 Dispute this row |
| BVF PARTNERS L P/IL Common Stock, $0.0001 par value per share | 9.0 | 25,525,000.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-000469 Dispute this row |
| BVF INC/IL Common Stock, $0.0001 par value per share | 9.0 | 25,525,000.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-000469 Dispute this row |
| LAMPERT MARK N Common Stock, $0.0001 par value per share | 9.0 | 25,525,000.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0000921895-26-000469 Dispute this row |
| RA Capital Management, L.P. Common Stock, $0.0001 par value per share | 9.9 | 28,857,208.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001346824-26-000045 Dispute this row |
| Peter Kolchinsky Common Stock, $0.0001 par value per share | 9.9 | 28,857,208.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001346824-26-000045 Dispute this row |
| Rajeev Shah Common Stock, $0.0001 par value per share | 9.9 | 28,857,208.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001346824-26-000045 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, $0.0001 par value per share | 9.9 | 28,857,208.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001346824-26-000045 Dispute this row |
| Maverick Capital, Ltd. Common Stock, $0.0001 par value per share | 6.7 | 18,970,913 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0001012975-26-000135 Dispute this row |
| Maverick Capital Management, LLC Common Stock, $0.0001 par value per share | 6.7 | 18,970,913 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0001012975-26-000135 Dispute this row |
| Lee S. Ainslie III Common Stock, $0.0001 par value per share | 6.7 | 18,970,913 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0001012975-26-000135 Dispute this row |
| Soleus Private Equity Fund III, L.P. Common Stock, par value $0.0001 per share | 0.6 | 1,680,160.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-015651 Dispute this row |
| Soleus Private Equity GP III, LLC Common Stock, par value $0.0001 per share | 0.6 | 1,680,160.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-015651 Dispute this row |
| Soleus PE GP III, LLC Common Stock, par value $0.0001 per share | 0.6 | 1,680,160.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-015651 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,715,586 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 131,968 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,828 |
Filings made before the SEC required XML are listed, not extracted.